Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV)-Reference-Cited by-同舟云学术

Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV)

Published:2022-09-20 Issue:11 Volume:20 Page:1413-1424
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Abdul Massih Sandra¹,Eke Ahizechukwu C.¹²^ORCID

Affiliation:

1. Division of Clinical Pharmacology & Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2. Division of Maternal Fetal Medicine, Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Funder

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2022.2125868

Reference104 articles.

1. World Health Organization (WHO). Hepatitis C. Cited 2022 Jun 30th. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c

2. Centers for Disease Control (CDC). Viral hepatitis surveillance report (2019). Cited 2022 Jun 11th. https://www.cdc.gov/hepatitis/statistics/2019surveillance/Introduction.htm

3. Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study

4. Hepatitis C Virus in Women of Childbearing Age, Pregnant Women, and Children

5. Perinatal transmission of hepatitis C virus: an update

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral Hepatitis in Pregnancy;Obstetrics & Gynecology;2023-09

2. Hepatitis C;The Lancet;2023-09